Sign In
Buy INMD
$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
InMode: My Pick For A Major Turnaround In 2026 And 2027
09:37am, Thursday, 28'th May 2026
InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD,
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
07:00am, Wednesday, 20'th May 2026
YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced the appointment of D
InMode to Present at Upcoming Investor Conferences and Events
08:30am, Wednesday, 13'th May 2026
YOKNEAM, Israel, May 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conf
InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript
03:21pm, Wednesday, 06'th May 2026
InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript
InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase
07:00am, Wednesday, 06'th May 2026
YOKNEAM, Israel, May 6, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for
Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd.
InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of “Hold” from Analysts
02:18am, Monday, 13'th Apr 2026
Shares of InMode Ltd. (NASDAQ: INMD - Get Free Report) have been assigned an average recommendation of "Hold" from the nine research firms that are currently covering the stock, Marketbeat.com reports
InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
08:30am, Tuesday, 24'th Mar 2026
YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer an
InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of “Hold” from Analysts
02:31am, Thursday, 19'th Mar 2026
Shares of InMode Ltd. (NASDAQ: INMD - Get Free Report) have received an average rating of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat.com reports. One resear
InMode (NASDAQ:INMD) Shares Gap Up – What’s Next?
01:41am, Sunday, 15'th Mar 2026
InMode Ltd. (NASDAQ: INMD - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $12.76, but opened at $13.71. InMode shares last traded at $13.5850, with a volume
InMode Announces New Share Repurchase Program
07:00am, Friday, 13'th Mar 2026
YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a
InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
02:22pm, Wednesday, 11'th Mar 2026
InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
InMode to Present at Upcoming Investor Conferences
08:00am, Thursday, 26'th Feb 2026
YOKNEAM, Israel, Feb. 26, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor con
InMode (INMD) Stock Slips As Board Ends Review
10:32am, Monday, 23'rd Feb 2026
The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that
InMode Announces Conclusion of Independent Transaction Committee Review
07:00am, Monday, 23'rd Feb 2026
YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independen
